Degenerative disorders of motor neurons include a range of progressive fatal diseases such as amyotrophic lateral sclerosis (ALS), spinal-bulbar muscular atrophy (SBMA), and spinal muscular atrophy (SMA). Although the causative genetic alterations are known for some cases, the molecular basis of many SMA and SBMA-like syndromes and most ALS cases is unknown. Here we show that missense point mutations in the cytoplasmic dynein heavy chain result in progressive motor neuron degeneration in heterozygous mice, and in homozygotes this is accompanied by the formation of Lewy-like inclusion bodies, thus resembling key features of human pathology. These mutations exclusively perturb neuron-specific functions of dynein
textabstractAmyotrophic Lateral Sclerosis (ALS) is an adult-onset neuro-degenerative disease. The de...
Background: Spinal muscular atrophy with lower extremity predominance (SMA-LED) is an autosomal domi...
Amyotrophic lateral sclerosis (ALS) is a debilitating and fatal late-onset neurodegenerative disease...
We have shown in a mouse model of motor neuron disease, the legs-at-odd-angles (Loa) mutant, and tha...
A single amino acid change, F580Y (Legs at odd angles (Loa), Dync1h1Loa), in the highly conserved an...
We have shown in a mouse model of motor neuron disease, the legs-at-odd-angles (Loa) mutant, and tha...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition characterized by motoneur...
Cytoplasmic dynein is responsible for the transport and delivery of cargoes in organisms ranging fro...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting motor neurons in the b...
Several recent studies have highlighted the role of axonal transport in the pathogenesis of motor ne...
Mutations in the DYNC1H1 gene encoding for dynein heavy chain cause two closely related human motor ...
Cytoplasmic dynein is responsible for the transport and delivery of cargoes in organisms ranging fro...
The molecular motor dynein and its associated regulatory subunit dynactin have been implicated in se...
Abstract Background Cytoplasmic dynein and its regulatory proteins have been implicated in neuronal ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition characterized by progress...
textabstractAmyotrophic Lateral Sclerosis (ALS) is an adult-onset neuro-degenerative disease. The de...
Background: Spinal muscular atrophy with lower extremity predominance (SMA-LED) is an autosomal domi...
Amyotrophic lateral sclerosis (ALS) is a debilitating and fatal late-onset neurodegenerative disease...
We have shown in a mouse model of motor neuron disease, the legs-at-odd-angles (Loa) mutant, and tha...
A single amino acid change, F580Y (Legs at odd angles (Loa), Dync1h1Loa), in the highly conserved an...
We have shown in a mouse model of motor neuron disease, the legs-at-odd-angles (Loa) mutant, and tha...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition characterized by motoneur...
Cytoplasmic dynein is responsible for the transport and delivery of cargoes in organisms ranging fro...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting motor neurons in the b...
Several recent studies have highlighted the role of axonal transport in the pathogenesis of motor ne...
Mutations in the DYNC1H1 gene encoding for dynein heavy chain cause two closely related human motor ...
Cytoplasmic dynein is responsible for the transport and delivery of cargoes in organisms ranging fro...
The molecular motor dynein and its associated regulatory subunit dynactin have been implicated in se...
Abstract Background Cytoplasmic dynein and its regulatory proteins have been implicated in neuronal ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition characterized by progress...
textabstractAmyotrophic Lateral Sclerosis (ALS) is an adult-onset neuro-degenerative disease. The de...
Background: Spinal muscular atrophy with lower extremity predominance (SMA-LED) is an autosomal domi...
Amyotrophic lateral sclerosis (ALS) is a debilitating and fatal late-onset neurodegenerative disease...